Diagnosing autoimmune conditions can sometimes be difficult, so any progress toward faster, cheaper, or more reliable testing methods could play a significant role in improving diagnosis and reducing time to treatment. Approval by the FDA is key to making such tests available commercially.
A New York startup company, Aesku.NY, has received FDA approval for tests to detect two of those autoimmune diseases, with tests for other diseases expected to follow.
The approved tests for celiac disease, and the connective tissue disorder, lupus, would still require patients ...
- Read Full Article...
- 4 comments
- 12,605 views